RxDoctor Payments DataLook up a doctor →

Lambros Stamatakis, MD

Urology · Washington, DCNPI 1962641332

Payments from drug & device makers

$992,425in general payments, 2019–2025

Across 156 payments — averaging $6361.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$956K
  • Ferring Pharmaceuticals Inc.$21K
  • Immunitybio, Inc.$5K
  • Urogen Pharma, Inc.$4K
  • Janssen Global Services, LLC$2K
  • Janssen Scientific Affairs, LLC$2K
  • plus $2K from 18 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$992,425 in reported general payments places this provider in the 95th percentile of 47 urology providers in District of Columbia.

See all urology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$204,003
Medicare patients
450
Services billed
1,278

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →